Renaissance Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,943	Closed	-$1.22M	–	295
2021 Q1	$1.22M	Buy	7,943 +65	+0.8%	+$8.83K	0.05%	139
2020 Q4	$988K	Buy	7,878 +260	+3%	+$29.1K	0.04%	151
2020 Q3	$773K	Buy	7,618 +37	+0.5%	+$3.77K	0.04%	151
2020 Q2	$738K	Sell	7,581 -65	-0.9%	-$6.05K	0.04%	155
2020 Q1	$635K	Buy	7,646 +469	+7%	+$45.7K	0.04%	150
2019 Q4	$798K	Buy	7,177 +2,001	+39%	+$206K	0.03%	159
2019 Q3	$514K	Buy	5,176 +29	+0.6%	+$2.88K	0.02%	195
2019 Q2	$510K	Sell	5,147 -79	-2%	-$7.54K	0.02%	204
2019 Q1	$576K	Sell	5,226 -319	-6%	-$33.3K	0.02%	182
2018 Q4	$510K	Sell	5,545 -406	-7%	-$41.1K	0.02%	192
2018 Q3	$656K	Buy	5,951 +165	+3%	+$17.2K	0.02%	186
2018 Q2	$540K	Buy	5,786 +373	+7%	+$32.1K	0.02%	197
2018 Q1	$449K	Buy	5,413 +149	+3%	+$13.2K	0.02%	205
2017 Q4	$479K	Buy	5,264 +23	+0.4%	+$1.91K	0.02%	189
2017 Q3	$399K	Buy	5,241 +2	+0%	+$151	0.01%	216
2017 Q2	$393K	Buy	5,239 +126	+2%	+$8.73K	0.01%	201
2017 Q1	$334K	Buy	+5,113	New	+$301K	0.01%	225